About the Authors
- Guillem Ramis
-
Affiliation Cancer Cell Biology Group, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS), Universitat de les Illes Balears, Illes Balears, Spain
- Elena Thomàs-Moyà
-
Affiliation Cancer Cell Biology Group, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS), Universitat de les Illes Balears, Illes Balears, Spain
- Silvia Fernández de Mattos
-
Affiliations Cancer Cell Biology Group, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS), Universitat de les Illes Balears, Illes Balears, Spain, Departament de Biologia Fonamental, Universitat de les Illes Balears, Illes Balears, Spain
- José Rodríguez
-
Current address: Hospital Severo Ochoa, Leganés, Madrid, Spain
Affiliation Cancer Cell Biology Group, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS), Universitat de les Illes Balears, Illes Balears, Spain
- Priam Villalonga
-
* E-mail: priam.villalonga@uib.es
Affiliations Cancer Cell Biology Group, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS), Universitat de les Illes Balears, Illes Balears, Spain, Departament de Biologia Fonamental, Universitat de les Illes Balears, Illes Balears, Spain
Competing Interests
The authors have read the journal's policy and have the following conflicts: Their laboratory has received research funding from Roche-Farma (Spain). However, Roche-Farma had no role whatsoever in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: GR SF JR PV. Performed the experiments: GR ETM PV. Analyzed the data: GR ETM SF JR PV. Wrote the paper: PV.